Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31336622 | 0.74 | GBA1 (0.44) | GBA1SIGMAR1MAPTGRM6 | |
| SCHEMBL23556332 | 0.70 | GBA1 (0.68) | GBA1SIGMAR1GAA | |
| SCHEMBL23556330 | 0.70 | GBA1 (0.68) | GBA1SIGMAR1GAA | |
| SCHEMBL24337537 | 0.70 | GBA1 (0.68) | GBA1SIGMAR1GAA | |
| SCHEMBL25484822 | 0.70 | GBA1 (0.68) | GBA1SIGMAR1GAA | |
| SCHEMBL12604944 | 0.69 | GBA1 (0.47) | GBA1SIGMAR1MAPTGAA | |
| SCHEMBL16316517 | 0.69 | GBA1 (0.47) | GBA1SIGMAR1MAPTGAA | |
| SCHEMBL14450892 | 0.69 | GBA1 (0.47) | GBA1SIGMAR1MAPTGAA | |
| SCHEMBL26186815 | 0.68 | MAPT (0.59) | GBA1SIGMAR1MAPTGAA | |
| SCHEMBL26187013 | 0.68 | MAPT (0.59) | GBA1SIGMAR1MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115043900-B | Peptoid compound and application thereof in preparation of 2019-nCoV main protease inhibitor | 深圳博瑞医药科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-115043900-A | Peptide-like compound and application thereof in preparation of 2019-nCoV main protease inhibitor | 深圳博瑞医药科技有限公司 | 2022-09-13 | — | — | CN | disclosed |